BenQ's one-stop dialysis strategy and its Malaysian medical devices license make revenue to rise.
2022/05/31
BenQ's dialysis overseas arrangement and one-stop strategy have worked well. In 2021, it has achieved outstanding results. The revenue of dialysis business has increased by nearly 80% compared with the same period last year, hitting a new high since the company was established in 2014.
Qisda Medical Fleet Adds New Member
2021/11/10
The Qisda fleet adds a new member! Qisda invested in the top five dialysis channels in China, K2 International, and officially entered the dialysis market channel.
BenQ Dialysis Technology Corp. Obtained Indonesian Medical Devices License, Deploying Overseas and Southeast Asian Markets
2021/11/09
The BenQ Qflux Dialyzer produced by BenQ Dialysis Technology, a subsidiary of Qisda, continues to expand its overseas market territory. In October 2011, it officially obtained the medical devices license issued by the Indonesian Ministry of Health and became the only manufacturer of dialyzers in Taiwan that has obtained the Indonesian license. It also set a new milestone for BenQ's overseas market arrangement.
BenQ actively expands the ASEAN medical market and participates in the Indonesia International Medical Exhibition
2019/10/23
BenQ Group has been actively deploying the ASEAN medical market in recent years, and has faith in the growth potential of Indonesia, and led the group's BenQ Dialysis Technology, BenQ Dental, and Lily Medical to go to Jakarta, Indonesia from October 23 to October 26 to participate in the 31st INDONESIAN HOSPITAL EXPO.
BenQ Arrangement in ASEAN Medical Market, and Thailand MDA Displays Ultrasound and Dialysis Products
2019/07/09
BenQ Group sees Thailand as the hub of medical equipment in the ASEAN region, and is also a region with high medical expenditure in ASEAN countries. BenQ Medical (stock code: 4116) and K2 International will participate in the "2019 MDA Thailand and ASEAN Medical Equipment Exhibition" in Bangkok, Thailand from July 10th to July 12th, actively expanding the Thailand and ASEAN markets.
Qisda Medical Fleet launched its Southeast Asia strategy, and its subsidiary K2 International went south to Thailand to set up a branch to expand the ASEAN market
2019/01/23
On the Jan 23rd, K2 International, invested by the group, officially established a branch in Thailand, becoming K2’s first stronghold in Southeast Asia. It will provide dialysis, medical beauty and other related products and services in Thailand, which will be replicated this experience to other Southeast Asian countries in the future.
Qisda Medical Fleet Adds New Members and with K2 International to Expand the Hemodialysis Market in Asia Pacific
2018/10/05
The Qisda Combined Fleet adds a new member! Qisda invested in the top five dialysis channels in China, K2 International, and officially entered the dialysis market channel.
English